EMA

Emera Incorporated

$50.85 -2.51%

Recent alerts on EMA

All signals →

SEC filing EMA Announces Election of 11 Directors, Voting Results: 99.75%, 99.50%, 96.64% Approval for Balfour, Bertram, Demone Resolutions

SEC filing EMA Reports Q1 2026 Results, Provides MD&A and Unaudited Condensed Consolidated Interim Financial Statements

News Emera Non-GAAP EPS of C$1.37

SEC filing EMA Reports $1.2B Revenue, $0.15 EPS, +8% YoY Growth, Announces $500M Green Bond Issue

SEC filing EMA Announces $750M Junior Subordinated Notes Offering, 6.65%/6.85% Reset Rate, 2056 Maturity, Net Proceeds for Debt Repayment

SEC filing EMA Certifies Annual Filings, Disclosure Controls, and Internal Control Over Financial Reporting Under COSO Framework

News Emera Non-GAAP EPS of C$0.55

News Software Selloff Seen as a Chance to Increase Exposure

News ‘Too Much’ Risk Premium Priced Into Silver, StoneX Says

Scanner Unusual volume (8.6x average)

News Univar Solutions and Ashland Forge Exclusive Partnership for Cellulose Ethers in Food and Beverage Sector Throughout EMEA – Company Announcement - FT.com

News Dr. Martens Revenue Drops on Europe, Middle East and Africa Weakness

News Have Conviction Into 'Strong Earnings,' BlackRock Says

News Otis Offers Eight Connected Vertical Mobility Solutions Across Gen3™ Platform for EMEA Customers

News Netflix Craters On Disappointing Guidance, Stock Buyback Pause

News Japanese Bond Rout Sends Yields to Record Highs

News New EMA Research Reveals AI Adoption Gap in Network Operations

News JPMorgan's Filippo Gori on Client Tariff Concern

News Titanbay establishes Swiss Advisory Board to support regional growth

News Goldman Sachs in charts: Q4 Americas revenue drops, EMEA sees double-digit gains

News Muni Bonds Start Year Strong as ‘January Effect‘ Emerges

News Emera Incorporated 4.25% REST PFD J declares CAD 0.2656 dividend

News Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results

News CME Group International Average Daily Volume Reaches Record 8.4 Million Contracts in 2025, Up 8% from 2024

News Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP

Get push alerts for EMA

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS